ADMAADMA BIOLOGICS, INC.

Nasdaq admabiologics.com


$ 10.36 $ 0.09 (0.93 %)    

Monday, 10-Jun-2024 13:29:53 EDT
QQQ $ 463.48 $ 0.69 (0.15 %)
DIA $ 388.23 $ -0.12 (-0.03 %)
SPY $ 534.28 $ 1.03 (0.19 %)
TLT $ 90.73 $ -0.30 (-0.33 %)
GLD $ 213.64 $ 0.55 (0.26 %)
$ 10.47
$ 10.27
$ 10.36 x 315
$ 10.37 x 100
$ 10.10 - $ 10.39
$ 3.06 - $ 10.86
1,749,853
na
2.48B
$ 0.63
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-28-2024 12-31-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-10-2023 03-31-2023 10-Q
6 03-23-2023 12-31-2022 10-K
7 11-09-2022 09-30-2022 10-Q
8 08-10-2022 06-30-2022 10-Q
9 05-11-2022 03-31-2022 10-Q
10 03-24-2022 12-31-2021 10-K
11 11-10-2021 09-30-2021 10-Q
12 08-11-2021 06-30-2021 10-Q
13 05-12-2021 03-31-2021 10-Q
14 03-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 03-13-2020 12-31-2019 10-K
19 11-06-2019 09-30-2019 10-Q
20 08-08-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 03-13-2019 12-31-2018 10-K
23 11-09-2018 09-30-2018 10-Q
24 08-10-2018 06-30-2018 10-Q
25 05-14-2018 03-31-2018 10-Q
26 03-29-2018 12-31-2017 10-K
27 11-03-2017 09-30-2017 10-Q
28 08-11-2017 06-30-2017 10-Q
29 05-12-2017 03-31-2017 10-Q
30 02-24-2017 12-31-2016 10-K
31 11-10-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-Q
33 05-13-2016 03-31-2016 10-Q
34 03-23-2016 12-31-2015 10-K
35 11-10-2015 09-30-2015 10-Q
36 08-11-2015 06-30-2015 10-Q
37 05-12-2015 03-31-2015 10-Q
38 03-09-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-11-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 raymond-james-maintains-strong-buy-on-adma-biologics-raises-price-target-to-10

Raymond James analyst Elliot Wilbur maintains ADMA Biologics (NASDAQ:ADMA) with a Strong Buy and raises the price target fro...

 cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-10

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

 hc-wainwright--co-maintains-buy-on-adma-biologics-raises-price-target-to-10

HC Wainwright & Co. analyst Raghuram Selvaraju maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price ta...

 mizuho-maintains-buy-on-adma-biologics-raises-price-target-to-12

Mizuho analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $10 to $12.

 adma-biologics-q1-2024-gaap-eps-008-beats-005-estimate-sales-81875m-beat-77275m-estimate

ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $0.05 ...

 hc-wainwright--co-reiterates-buy-on-adma-biologics-raises-price-target-to-75

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price t...

 adma-biologics-reports-fda-approvals-of-extended-room-temperature-storage-conditions-for-asceniv--bivigam

The room temperature approval applies to all existing ASCENIV and BIVIGAM lots currently in the commercial supply chain as well...

 piper-sandler-maintains-buy-on-adma-biologics-raises-price-target-to-10

Piper Sandler analyst Anthony Petrone maintains ADMA Biologics (NASDAQ:ADMA) with a Buy and raises the price target from $9 ...

 cantor-fitzgerald-maintains-overweight-on-adma-biologics-raises-price-target-to-8

Cantor Fitzgerald analyst Kristen Kluska maintains ADMA Biologics (NASDAQ:ADMA) with a Overweight and raises the price targe...

 hc-wainwright--co-reiterates-buy-on-adma-biologics-maintains-6-price-target

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates ADMA Biologics (NASDAQ:ADMA) with a Buy and maintains $6 price...

 recap-adma-biologics-q4-earnings
Recap: ADMA Biologics Q4 Earnings
02/28/2024 21:30:30